BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18522703)

  • 1. The predicted impact of immunosuppression upon population age-intensity profiles for schistosomiasis.
    Mitchell KM; Mutapi F; Woolhouse ME
    Parasite Immunol; 2008 Sep; 30(9):462-70. PubMed ID: 18522703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups.
    Mutapi F; Mduluza T; Roddam AW
    Immunol Lett; 2005 Jan; 96(2):231-40. PubMed ID: 15585328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
    Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
    Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasite glycans and antibody-mediated immune responses in Schistosoma infection.
    van Diepen A; Van der Velden NS; Smit CH; Meevissen MH; Hokke CH
    Parasitology; 2012 Aug; 139(9):1219-30. PubMed ID: 22423613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal nematodes: the Karkar experience.
    Pritchard DI
    P N G Med J; 1995 Dec; 38(4):295-9. PubMed ID: 9522871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology of schistosomiasis.
    Bull World Health Organ; 1974; 51(6):553-95. PubMed ID: 4219757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunity in human schistosomiasis: hope for a vaccine].
    Kouriba B; Traore B; Diemert D; Thera MA; Dolo A; Tounkara A; Doumbo O
    Med Trop (Mars); 2010 Apr; 70(2):189-97. PubMed ID: 20486361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel immunomic technologies for schistosome vaccine development.
    McWilliam HE; Driguez P; Piedrafita D; McManus DP; Meeusen EN
    Parasite Immunol; 2012 May; 34(5):276-84. PubMed ID: 22486551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody against schistosome and schistosome infection and reinfection].
    Li YF; Xie SY; Lin DD
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Apr; 24(2):217-21, 227. PubMed ID: 22799175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent immune responses in late infection and after treatment in experimental Schistosoma bovis infections in goats.
    Sörén K; Monrad J; Johansen MV; Lindberg R
    Res Vet Sci; 2009 Jun; 86(3):472-8. PubMed ID: 19027127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired immunity on a schistosomiasis transmission model - fitting the data.
    Yang HM; Coutinho FA; Massad E
    J Theor Biol; 1997 Oct; 188(4):495-506. PubMed ID: 9367736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging and immune response in chronic human schistosomiasis.
    Comin F; Speziali E; Correa-Oliveira R; Faria AM
    Acta Trop; 2008; 108(2-3):124-30. PubMed ID: 18582841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A theoretical framework for the immunoepidemiology of blocking antibodies to helminth infection.
    Woolhouse ME
    Parasite Immunol; 1994 Aug; 16(8):415-24. PubMed ID: 7808762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosome membrane proteins as vaccines.
    Loukas A; Tran M; Pearson MS
    Int J Parasitol; 2007 Mar; 37(3-4):257-63. PubMed ID: 17222846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of host factors on the schistosome-killing process induced by praziquantel].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Jun; 26(3):217-25. PubMed ID: 19160970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials.
    Capron A; Riveau G; Capron M; Trottein F
    Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse genetics and the study of the immune response to schistosomes.
    Pearce EJ; Freitas TC
    Parasite Immunol; 2008 Apr; 30(4):215-21. PubMed ID: 18324924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosome glycans and innate immunity.
    Hokke CH; Yazdanbakhsh M
    Parasite Immunol; 2005; 27(7-8):257-64. PubMed ID: 16138846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.